PFE Pfizer
$27.50 +0.33%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.33%
YTD
+4.70%
P/E
36.23
P/B
1.64
ROE
4.9%
Div yield
5.4%
Beta
0.3
Market cap
$157.0B
RSI (14)
44
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$27.48
Close
$27.50
VWAP (n/a)
—
Day high
$27.71
Day low
$27.20
Volume
24.0M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Is Pfizer (PFE) a Good or Bad Investment at Today’s Price?
Yahoo Finance · Oct 6
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
Yahoo Finance · Oct 6
PFE vs. JNJ: Which Stock Is the Better Value Option?
Yahoo Finance · Oct 6
Pfizer Declares Fourth-Quarter 2026 Dividend
Yahoo Finance · Oct 6
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher
Yahoo Finance · Oct 6
Pfizer’s $6.49 Billion Prevnar Franchise Faces a New Challenger
Yahoo Finance · Oct 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Jun 18, 2026 View → 8-K Jun 18, 2026 View → 10-Q May 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PFE. Try it in the Lab to size a position and see the risk.